Bhagiradha Chemicals FY26 PAT Rises 31% to ₹18.2 Cr
Bhagiradha Chemicals & Industries Limited reported a 31% increase in consolidated net profit to ₹18.2 crore for FY26, with revenue rising 22% to ₹535.9 crore. Q4 performance showed a turnaround to a ₹4.1 crore profit, supported by a 220% surge in EBITDA to ₹19.4 crore. The company commenced Phase I of the Bheema Fine project and launched three new molecules, positioning for growth in FY27.
*this image is generated using AI for illustrative purposes only.
Bhagiradha Chemicals & Industries Limited has released its investor presentation for the quarter and year ended March 31, 2026. The company reported a consolidated net profit of ₹18.2 crore for the fiscal year 2025-26, a 31% increase compared to ₹13.9 crore in the previous year. Revenue from operations for the year stood at ₹535.9 crore, up 22% from ₹440.5 crore in FY25. The growth was driven by volume expansion and improved value realizations, supported by better capacity utilization and operational efficiency.
Q4 Performance
For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹4.1 crore, a significant turnaround from a loss of ₹0.9 crore in the same quarter of the previous year. Consolidated revenue for Q4 FY26 reached ₹158.1 crore, a 29% year-on-year increase from ₹122.6 crore. EBITDA for the quarter surged 220% to ₹19.4 crore, with margins expanding to 12.3% from 5.0% in the prior year. The management attributed the performance to improved realizations, a favorable product mix, and tapering raw material prices.
Financial Highlights
The following table summarizes the consolidated financial performance for the year ended March 31, 2026:
| Particulars (₹ in Cr.) | Year Ended Mar-26 | Year Ended Mar-25 | YoY Growth |
|---|---|---|---|
| Revenue from Operations | 535.9 | 440.5 | 22% |
| EBITDA | 57.1 | 36.9 | 55% |
| Profit After Tax | 18.2 | 13.9 | 31% |
On a standalone basis, the company reported a net profit of ₹2,623.66 lakhs for FY26, with revenue from operations at ₹52,122.21 lakhs. Total expenses for the year amounted to ₹49,675.56 lakhs.
Operational Updates
Management commentary highlighted the successful commencement of Phase I of the Bheema Fine project, with a capitalization of approximately ₹400 crores. The company launched three new molecules during the year and initiated relationships with 19 new customers. Lower power and fuel costs, following the commencement of the solar project, further supported margins. Looking ahead, the company expects a meaningful ramp-up in operations to unlock full revenue potential in FY27.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE414D01027/cdcaa5394e774bd7.pdf
Historical Stock Returns for Bhagiradha Chemicals & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.67% | -1.85% | -5.65% | -1.90% | -19.76% | -66.31% |
How will the full ramp-up of the Bheema Fine project's Phase I capacity impact Bhagiradha Chemicals' revenue and margin trajectory in FY27?
Could the addition of 19 new customers and three new molecules signal a strategic shift toward higher-margin specialty chemicals, and how might this reshape the company's product mix going forward?
With raw material prices tapering and the solar project reducing power costs, how sustainable are the current EBITDA margin levels if input costs reverse course?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
